Normal view MARC view ISBD view

Successful open abdomen treatment for multiple ischemic duodenal perforated ulcers in dermatomyositis. [electronic resource]

By:

Villa, Roberta

Contributor(s):

Producer: 20150618Description: 48 p. digitalISSN:

1749-7922

Online resources:

Available from publisher's website

In: World journal of emergency surgery : WJES vol. 9

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

to post a comment.

Back to results

21541 Natural history of severe duodenal ulcer disease.
by Konar, A
21542 Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori.
by Moayyedi, P
21543 [Absence of bleeding recurrence of peptic ulcer after long term follow-up of successful eradication of Helicobacter pylori].
by Amendola, M
21544 Helicobacter pylori type I strains among Austrian and Portuguese patients with gastritis, peptic ulcer or gastric cancer.
by Bach, S
21545 Increased gastric epithelial cell apoptosis associated with colonization with cagA + Helicobacter pylori strains.
by Moss, S F
21546 [Application of serology to confirm the eradication of Helicobacter pylori in peptic ulcer patients].
by Figueroa, G
21547 Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori.
by Savarino, V
21548 Helicobacter pylori therapy: first-line options and rescue regimen.
by Gisbert, J P
21549 Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection.
by Talley, N J
21550 Are goats naturally resistant to gastric Helicobacter infection?
by Gueneau, Pulchérie
21551 Management of dyspepsia across the primary-secondary healthcare interface.
by Hungin, A P
21552 Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations.
by Kita, Tomoko
21553 Histopathology of the gastroesophageal junction: a study on 36 operation specimens.
by Sarbia, Mario
21554 Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction.
by Kinjo, Kunihiro
21555 Review of esomeprazole in the treatment of acid disorders.
by Johnson, David A
21556 [Helicobacter pylori, non-steroidal anti-inflammatory drugs and aspirin: a new piece of the puzzle].
by Lesur, G
21557 Helicobacter pylori and nonsteroidal anti-inflammatory drugs.
by Chan, F K
21558 Early weaning and culling eradicated Helicobacter hepaticus from an acetylcholinesterase knockout 129S6/SvEvTac mouse colony.
by Duysen, Ellen Gail
21559 Lack of consistency in the associations of Helicobacter pylori seropositivity with Se and Le polymorphisms among Japanese.
by Hamajima, Nobuyuki
21560 Attenuation of hydrophobic phospholipid barrier is an early event in Helicobacter felis-induced gastritis in mice.
by Lichtenberger, L M